Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding. See what Iranian state media is saying today.
❓ Unknown

Sale of 150 Million Toman Drug Containing Distilled Water in the Informal Market / Buy Medicines Through Authorized Channels

13h ago October 31, 2026 1 min read 📰 ISNA
📋 Key Takeaway

A case of pharmaceutical fraud has been uncovered in Iran, involving a drug worth 150 million tomans that was sold with its contents replaced by distilled water. The Food and Drug Organization is warning consumers to purchase medicines only through authorized channels to avoid such scams.

🔍 Quick Context Guide
💡 Bottom Line: The discovery of pharmaceutical fraud underscores the risks consumers face in Iran's informal market.

👥 Key Players

Food and Drug Organization (FDO) MENTIONED
Regulatory body overseeing pharmaceuticals in Iran
"They are responsible for ensuring the safety and efficacy of medications in Iran, impacting public health."
Consumers MENTIONED
General public purchasing medications
"They are directly affected by pharmaceutical fraud, which can endanger their health."

📰 What Happened

A case of pharmaceutical fraud was uncovered in Iran where a drug worth 150 million tomans was sold with its contents replaced by distilled water. The Food and Drug Organization has issued a warning to consumers to buy medicines only from authorized sources.

  • The fraudulent drug was marketed as the original medication despite being diluted with distilled water.
  • The FDO has emphasized the importance of purchasing medications through authorized channels to avoid scams.

💡 Why It Matters

🇮🇷 For Iran: This incident raises concerns about public health and the integrity of the pharmaceutical market in Iran.
🌍 Regional: It reflects broader issues of regulatory challenges in healthcare that could affect neighboring countries.
🌐 International: International observers may view this as indicative of the challenges Iran faces in managing its healthcare system amid sanctions.

📚 Background

Iran has been grappling with economic sanctions that have impacted its healthcare system, leading to increased reliance on informal markets. This has raised concerns about the quality and safety of medications.

Pharmaceutical regulation in Iran Impact of sanctions on Iranian healthcare
📡 Source: STATE MEDIA
📊 Confidence: 70%
As a state announcement, the information may reflect the government's efforts to address public health issues and maintain trust in official channels.

The Director General of the Inspection and Performance Management Office of the Food and Drug Organization announced the identification of a case of pharmaceutical fraud in the informal market, where a drug valued at 150 million tomans was sold with its contents replaced by distilled water, being marketed as the original medication.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →